Latest common stock for MRM: $20M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (December 2025), MRM shows a common stock of $20M. That compares with $350M in the prior-year period — down 94.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MRM's common stock is now $20M (was $350M) — a 94.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether MEDIROM Healthcare Technologies is outperforming or lagging.
Tracking MRM's common stock over time shows whether MEDIROM Healthcare Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $350M in the prior-year period — down 94.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has MEDIROM Healthcare Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $20M) with ownership activity and broader fundamentals.
MEDIROM Healthcare Technologies's common stock is $20M; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.